Nefopam hydrochloride is a centrally acting, non-opioid analgesic of the benzoxazocine class, primarily indicated for the management of moderate to severe acute or chronic pain. Analytical laboratories… Read more
Nefopam hydrochloride is a centrally acting, non-opioid analgesic of the benzoxazocine class, primarily indicated for the management of moderate to severe acute or chronic pain. Analytical laboratories utilize this category to source essential compounds required for comprehensive impurity profiling and method validation during pharmaceutical development. The collection provides high-quality reference standards for the active pharmaceutical ingredient, alongside critical process-related impurities such as N-desmethyl nefopam and specific degradation products. Furthermore, researchers can access key metabolites, including the N-oxide and glucuronide forms, to support pharmacokinetic studies and metabolic research. Stable isotope labelled compounds, such as deuterium-labelled variants, are also included to serve as internal standards for mass spectrometry-based quantitative analysis. These high-purity materials are vital for maintaining rigorous quality control standards and ensuring the accuracy of analytical testing across the drug product lifecycle.
